BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32697040)

  • 1. Use of cytology centrifuged supernatants improves cost and turnaround time for targeted next generation sequencing.
    Gokozan H; Harbhajanka A; Bomeisl P; Michael CW; Sadri N
    Diagn Cytopathol; 2020 Dec; 48(12):1167-1172. PubMed ID: 32697040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
    Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
    Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
    Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
    Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
    Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
    Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
    Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a 50-gene next generation sequencing panel with post-centrifuge supernatant cytology fluid in non-small-cell lung cancer.
    Tafoya M; Judd A; Chiotti K; Dearen K; Jiron K; Chabot-Richards D; Broehm CJ
    Diagn Cytopathol; 2021 Nov; 49(11):1173-1178. PubMed ID: 34339108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
    Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
    Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
    Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
    Seto K; Masago K; Fujita S; Haneda M; Horio Y; Hida T; Kuroda H; Hosoda W; Okubo KI
    Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and comparison of EGFR mutations from supernatants that contain cell-free DNA and cell pellets from FNA non-small cell lung cancer specimens.
    Wu W; Huang Y; Guo J; Xie X; Li H; Cao Z; Wei H; Wu C
    Cancer Cytopathol; 2020 Aug; 128(8):545-552. PubMed ID: 32286726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer.
    Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ
    Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
    Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
    Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling.
    Roy-Chowdhuri S; Mehrotra M; Bolivar AM; Kanagal-Shamanna R; Barkoh BA; Hannigan B; Zalles S; Ye W; Duose D; Broaddus R; Staerkel G; Wistuba I; Medeiros LJ; Luthra R
    Mod Pathol; 2018 Jul; 31(7):1036-1045. PubMed ID: 29463880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic concordance of non-small cell lung carcinoma subtypes between biopsy and cytology specimens obtained during the same procedure.
    Ebrahimi M; Auger M; Jung S; Fraser RS
    Cancer Cytopathol; 2016 Oct; 124(10):737-743. PubMed ID: 27172103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
    Karnes HE; Duncavage EJ; Bernadt CT
    Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.